Burden and epidemiology of Campylobacter species in acute enteritis cases in Burkina Faso.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
09 Aug 2024
Historique:
received: 03 06 2024
accepted: 02 08 2024
medline: 10 8 2024
pubmed: 10 8 2024
entrez: 9 8 2024
Statut: epublish

Résumé

Campylobacter spp. is a significant etiological agent of bacterial gastroenteritis globally. In Burkina Faso (BFA), the actual impact of this pathogen on gastroenteritis is considerably underestimated, primarily due to inadequate surveillance systems. This study aimed to investigate the proportion of Campylobacter species responsible for acute gastroenteritis among patients of all ages in urban and rural areas of BFA, using molecular biology techniques. Between 2018 and 2021, faecal specimens were obtained from 1,295 individuals presenting with acute gastroenteritis. These samples underwent screening for the Campylobacter coli/jejuni/lari complex utilizing real-time polymerase chain reaction (PCR) assays. Subsequently, positive samples were subjected to species-level differentiation through the application of species-specific primers. Campylobacter spp. was detected in 25.0% (324/1,295) of the samples analysed. The majority of positive samples (95%, 308/324) were obtained from children under 5 years of age. Species identification was performed on a subset of 114 isolates, revealing 51 Campylobacter jejuni, 10 Campylobacter coli, and 53 Campylobacter isolates that remained unspeciated. This study reveals a significant prevalence of Campylobacter species among patients with acute gastroenteritis, with a particularly high incidence observed in children under 5 years of age. Based on these findings, the implementation of routine Campylobacter surveillance in public health laboratories is strongly recommended to better monitor and address this health concern.

Sections du résumé

BACKGROUND BACKGROUND
Campylobacter spp. is a significant etiological agent of bacterial gastroenteritis globally. In Burkina Faso (BFA), the actual impact of this pathogen on gastroenteritis is considerably underestimated, primarily due to inadequate surveillance systems.
OBJECTIVES OBJECTIVE
This study aimed to investigate the proportion of Campylobacter species responsible for acute gastroenteritis among patients of all ages in urban and rural areas of BFA, using molecular biology techniques.
STUDY DESIGN & METHODS METHODS
Between 2018 and 2021, faecal specimens were obtained from 1,295 individuals presenting with acute gastroenteritis. These samples underwent screening for the Campylobacter coli/jejuni/lari complex utilizing real-time polymerase chain reaction (PCR) assays. Subsequently, positive samples were subjected to species-level differentiation through the application of species-specific primers.
RESULTS RESULTS
Campylobacter spp. was detected in 25.0% (324/1,295) of the samples analysed. The majority of positive samples (95%, 308/324) were obtained from children under 5 years of age. Species identification was performed on a subset of 114 isolates, revealing 51 Campylobacter jejuni, 10 Campylobacter coli, and 53 Campylobacter isolates that remained unspeciated.
CONCLUSIONS CONCLUSIONS
This study reveals a significant prevalence of Campylobacter species among patients with acute gastroenteritis, with a particularly high incidence observed in children under 5 years of age. Based on these findings, the implementation of routine Campylobacter surveillance in public health laboratories is strongly recommended to better monitor and address this health concern.

Identifiants

pubmed: 39123104
doi: 10.1186/s12879-024-09709-y
pii: 10.1186/s12879-024-09709-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

808

Informations de copyright

© 2024. The Author(s).

Références

Kvalsvig A, Baker MG, Sears A, French N, Bacteria. Campylobacter. Encycl Food Saf. 2014;1:369–80.
doi: 10.1016/B978-0-12-378612-8.00089-5
Ruiz-Palacios GM. The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. Clin Infect Dis. 2007;44(5):701–3.
doi: 10.1086/509936 pubmed: 17278063
Gharst G, Oyarzabal OA, Hussain SK. Review of current methodologies to isolate and identify Campylobacter spp from foods. J Microbiol Methods [Internet]. 2013 Oct [cited 2023 Oct 26];95(1):84–92. https://pubmed.ncbi.nlm.nih.gov/23899774/
Padungton P, Kaneene JB. Campylobacter spp in human, chickens, pigs and their antimicrobial resistance. J Vet Med Sci [Internet]. 2003 [cited 2023 Oct 25];65(2):161–70. https://pubmed.ncbi.nlm.nih.gov/12655109/
Iglesias-Torrens Y, Miró E, Guirado P, Llovet T, Muñoz C, Cerdà-Cuéllar M et al. Population structure, antimicrobial resistance, and virulence-associated genes in Campylobacter jejuni isolated from three ecological niches: gastroenteritis patients, broilers, and wild birds. Front Microbiol [Internet]. 2018 Aug 2 [cited 2023 Oct 25];9(AUG). Available from: /pmc/articles/PMC6083060/.
Wieczorek K, Osek J. Antimicrobial resistance mechanisms among Campylobacter. Biomed Res Int. 2013;2013.
Bullman S, O’leary J, Corcoran D, Sleator RD. SHORT REPORT Molecular-based detection of non-culturable and emerging Campylobacteria in patients presenting with gastroenteritis. 2021; https://doi.org/10.1017/S0950268811000859
Sangaré L, Nikiéma AK, Zimmermann S, Sanou I, Congo-Ouédraogo M, Diabaté A. et al. Campylobacter Spp Epidemiology and Antimicrobial Susceptibility in a Developing Country, Burkina Faso (West Africa). African J Clin Exp Microbiol [Internet]. 2012 Mar 12 [cited 2020 Jul 4];13(2):110–7. https://www.ajol.info/index.php/ajcem/article/view/74704
Buss JE, Cresse M, Doyle S, Buchan BW, Craft DW, Young S. Campylobacter culture fails to correctly detect Campylobacter in 30% of positive patient stool specimens compared to non-cultural methods. Eur J Clin Microbiol Infect Dis. 2019;38(6):1087–93.
doi: 10.1007/s10096-019-03499-x pubmed: 30783889 pmcid: 6520473
Coulidiaty AGV, Sanou A, Houngbedji CA, Djibougou DA, Dicko A, Kobo G et al. Prevalence and sensitivity to antibiotics of Campylobacter spp in chicken, farmers and soil in Bobo-Dioulasso, Burkina Faso. 2021; 48 [Internet]. 2021 Feb 9 [cited 2023 Apr 4];4(8). https://www.one-health.panafrican-med-journal.com/content/article/4/8/full
Buchan BW, Olson WJ, Pezewski M, Marcon MJ, Novicki T, Uphoff TS et al. Clinical evaluation of a real-time PCR assay for identification of Salmonella, Shigella, Campylobacter (Campylobacter jejuni and C. coli), and shiga toxin-producing Escherichia coli isolates in stool specimens. J Clin Microbiol [Internet]. 2013 Dec [cited 2023 Nov 14];51(12):4001–7. https://doi.org/10.1128/jcm.02056-13
Karikari AB, Obiri-Danso K, Frimpong EH, Krogfelt KA. Antibiotic Resistance in Campylobacter isolated from patients with gastroenteritis in a Teaching Hospital in Ghana. Open J Med Microbiol. 2017;07(01):1–11.
doi: 10.4236/ojmm.2017.71001
Ohanu ME, Offune J. The prevalence of Campylobacter in childhood diarrhoea in Enugu state of Nigeria. J Commun Dis. 2009;41(2):117–20.
pubmed: 22010500
Sawadogo S, Diarra B, BIsseye C, Compaore TR, Djigma FW, Ouermi D, et al. Molecular diagnosis of Shigella, Salmonella and Campylobacter by multiplex real-time PCR in stool culture samples in Ouagadougou (Burkina Faso). Sudan J Med Sci. 2017;12(3):163.
doi: 10.18502/sjms.v12i3.931
Bonkoungou IJO, Haukka K, Österblad M, Hakanen AJ, Traoré AS, Barro N et al. Bacterial and viral etiology of childhood diarrhea in Ouagadougou, Burkina Faso. BMC Pediatr [Internet]. 2013 Mar 19 [cited 2020 Jun 5];13(1):36. https://bmcpediatr.biomedcentral.com/articles/ https://doi.org/10.1186/1471-2431-13-36
Schubert G, Achi V, Ahuka S, Belarbi E, Bourhaima O, Eckmanns T et al. The African Network for Improved Diagnostics, Epidemiology and Management of common infectious Agents. BMC Infect Dis [Internet]. 2021 Dec 1 [cited 2022 Oct 10];21(1):1–10. https://bmcinfectdis.biomedcentral.com/articles/ https://doi.org/10.1186/s12879-021-06238-w
Persson S, Olsen KEP. Multiplex PCR for identification of Campylobacter coli and Campylobacter jejuni from pure cultures and directly on stool samples. J Med Microbiol [Internet]. 2005 Nov [cited 2023 Nov 6];54(Pt 11):1043–7. https://pubmed.ncbi.nlm.nih.gov/16192435/
Hlashwayo DF, Sigaúque B, Noormahomed EV, Afonso SMS, Mandomando IM, Bila CG. A systematic review and meta-analysis reveal that Campylobacter spp and antibiotic resistance are widespread in humans in sub-Saharan Africa. PLoS One [Internet]. 2021 Jan 27 [cited 2024 Feb 15];16(1):1–21. https://typeset.io/papers/a-systematic-review-and-meta-analysis-reveal-that-4qivbpwsum
Deblais L, Ojeda A, Brhane M, Mummed B, Hassen KA, Ahmedo BU et al. Prevalence and Load of the Campylobacter Genus in Infants and Associated Household Contacts in Rural Eastern Ethiopia: a Longitudinal Study from the Campylobacter Genomics and Environmental Enteric Dysfunction (CAGED) Project. Appl Environ Microbiol [Internet]. 2023 Jul 1 [cited 2024 Feb 26];89(7). https://doi.org/10.1128/aem.00424-23
Kwack WG, Lim YJ, Kwon KH, Chung JW, Oh JY. Outcomes and clinical relevance of stool multiplex bacterial polymerase chain reaction in patients with acute diarrhea: Single center experience. Korean J Intern Med [Internet]. 2020 Mar 1 [cited 2020 Jul 4];35(2):300–9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061005/
James A, Platts-Mills, Liu J, Gratz J, Esto M, Amour C, Swai N et al. Detection of Campylobacter in Stool and Determination of Significance by Culture, Enzyme Immunoassay, and PCR in. 2014 [cited 2020 Jun 18];52(4):1074–80. http://jcm.asm.org/
Asuming-Bediako N, Parry-Hanson Kunadu A, Abraham S, Habib I. Campylobacter at the Human–Food Interface: The African Perspective. Pathogens [Internet]. 2019 Jun 25 [cited 2020 Jul 6];8(2):87. https://www.mdpi.com/2076-0817/8/2/87

Auteurs

Ange Oho Roseline Badjo (AOR)

Laboratory of Emerging and Re-emerging Pathogens, Nazi Boni University, 01 BP 1091, Bobo Dioulasso, Burkina Faso. angebadjo@yahoo.fr.

Nongodo Firmin Kabore (NF)

Centre MURAZ, Institut National de Santé Publique, Bobo Dioulasso, Burkina Faso.

Arsène Zongo (A)

Centre MURAZ, Institut National de Santé Publique, Bobo Dioulasso, Burkina Faso.

Kobo Gnada (K)

Centre MURAZ, Institut National de Santé Publique, Bobo Dioulasso, Burkina Faso.

Aminata Ouattara (A)

Laboratory of Emerging and Re-emerging Pathogens, Nazi Boni University, 01 BP 1091, Bobo Dioulasso, Burkina Faso.
Bacteriology and Virology Department, Souro Sanou University Hospital, Bobo Dioulasso, Burkina Faso.

Merci Muhigwa (M)

Laboratory of Emerging and Re-emerging Pathogens, Nazi Boni University, 01 BP 1091, Bobo Dioulasso, Burkina Faso.

Soumeya Ouangraoua (S)

Centre MURAZ, Institut National de Santé Publique, Bobo Dioulasso, Burkina Faso.

Armel Poda (A)

Laboratory of Emerging and Re-emerging Pathogens, Nazi Boni University, 01 BP 1091, Bobo Dioulasso, Burkina Faso.
Centre MURAZ, Institut National de Santé Publique, Bobo Dioulasso, Burkina Faso.
Department of Infectious Diseases, Souro Sanou University Hospital, Bobo Dioulasso, Burkina Faso.

Satouro Arsène Some (SA)

Centre MURAZ, Institut National de Santé Publique, Bobo Dioulasso, Burkina Faso.

Grit Schubert (G)

Robert Koch Institute, Berlin, Germany.

Tim Eckmanns (T)

Robert Koch Institute, Berlin, Germany.

Fabian H Leendertz (FH)

Helmholtz Institute for One Health, Greifswald, Germany.

Essia Belarbi (E)

Robert Koch Institute, Berlin, Germany.

Abdoul-Salam Ouedraogo (AS)

Laboratory of Emerging and Re-emerging Pathogens, Nazi Boni University, 01 BP 1091, Bobo Dioulasso, Burkina Faso.
Centre MURAZ, Institut National de Santé Publique, Bobo Dioulasso, Burkina Faso.
Bacteriology and Virology Department, Souro Sanou University Hospital, Bobo Dioulasso, Burkina Faso.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH